Medline Inc. Sale of Stock, Consideration Received on Transaction
Medline Inc. (MDLN) had Sale of Stock, Consideration Received on Transaction of $2.70 billion as of 2026-05-28, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedOnTransaction · last filed 2026-08-05
- 2026-05-28: Sale of Stock, Consideration Received on Transaction $2.70B.
- 2026-03-10: Sale of Stock, Consideration Received on Transaction $3.50B.
| Period end | Sale of Stock, Consideration Received on Transaction |
|---|---|
| 2026-05-28 | $2.70B 10-Q · filed 2026-08-05 |
| 2026-03-10 | $3.50B 10-Q · filed 2026-08-05 |